Screener
Tectonic Therapeutics TECX Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Tectonic Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Tectonic Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212016
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Commitments and contingencies (Note 10) | ||
| Stockholders’ Equity: | ||
| Common stock, $0.0001 par value; 150,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 18,830,436 and 18,738,249 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 2 | 2 |
| Additional paid-in capital | 478,393 | 474,160 |
| Accumulated other comprehensive loss | — | (96) |
| Accumulated deficit | (247,978) | (222,737) |
| Total stockholders’ equity | 230,417 | 251,329 |
| Total liabilities and stockholders’ equity | $246,577 | $261,038 |
Item 1. Financial Statements.
FAQ
- What is Tectonic Therapeutics's total equity?
- Tectonic Therapeutics (TECX) reported total equity of $230.42M in Q1 2026.
- How has Tectonic Therapeutics's total equity changed year-over-year?
- Tectonic Therapeutics's total equity decreased by 23.5% year-over-year, from $301.04M to $230.42M.
- What is the long-term trend for Tectonic Therapeutics's total equity?
- Over 5 years (2020 to 2025), Tectonic Therapeutics's total equity has grown at a -0.2% compound annual growth rate (CAGR), from $254.34M to $251.33M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Tectonic Therapeutics's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude